Stay COVID-safe

While it is not mandatory to self-isolate if you test positive to COVID-19, it is recommended you stay home and take steps to protect others.

If you test positive on a rapid antigen test (RAT) please register this with Service NSW. Registering your result can help you access medical support from NSW Health, including antiviral medicines if you are eligible.

Read more information on how to stay COVID-safe.

Accessible COVID-19 information for people with disability

Vaccination

The vaccination requirements in the Public Health (COVID-19 Care Services) Order (No 3) 2022 ended at 11.59pm on 30 November 2022. All requirements, provisions and exemptions under this Public Health Order have been repealed.

Requirements for COVID-19 vaccination of workers have transitioned to a workplace health and safety risk assessment model. As such, staff may need to provide proof of vaccination to their employer if requested.

If you require further information about COVID-19 and vaccines, you can contact:

  • National Coronavirus and COVID-19 Vaccine Helpline on 1800 020 080 (24/7)
  • Coronavirus Disability Information Helpline on 1800 643 787
  • COVID-19 vaccine disability team.

Antiviral resources

These resources have been developed to guide discussions between residents and their families with their GP regarding the use of antiviral medicines:

  • COVID-19 and flu antiviral medicines – Advice for people at high risk of severe illness
    A fact sheet for people at high risk of severe illness, including residents of RDCFs and their loved ones to help guide decisions about using antivirals for COVID-19 and influenza (flu) treatment and prevention.
  • Antiviral pre-assessment form for people at higher risk of severe illness
    This form should be completed by a GP in consultation with the resident (and their guardian where appropriate) to collaboratively form a plan about what antiviral medicines would be best for them. The pre-assessment form does not replace the requirement for a GP to prescribe a medication, but it will help speed up access to antiviral medicines if the person tests positive to COVID-19 or influenza.
  • Influenza and COVID-19 antiviral medicines
    A fact sheet for clinicians to provide guidance on the use of antiviral medicines for COVID-19 and influenza (oseltamivir, molnupiravir and nirmatrelvir/ritonavir).

Further resources

Commonwealth resources

NDIS resources

Other resources


Current as at: Tuesday 20 December 2022
Contact page owner: Health Protection NSW